Literature DB >> 11106933

The calcium-independent protein kinase C participates in an early process of CD3/CD28-mediated induction of thymocyte apoptosis.

A Asada1, Y Zhao, H Komano, T Kuwata, M Mukai, K Fujita, Y Tozawa, R Iseki, H Tian, K Sato, Y Motegi, R Suzuki, M Yokoyama, M Iwata.   

Abstract

Thymocyte negative selection eliminates self-reactive clones and involves both a T-cell receptor (TCR)/CD3-mediated signal and a costimulatory signal, which can be delivered via CD28. Anti-CD3/anti-CD28-triggered apoptosis in isolated CD4+CD8+ thymocytes in vitro provides a basic model for negative selection. Effects of isoform-selective and non-isoform-selective inhibitors of protein kinase C (PKC) on this apoptotic process suggest that activation of Ca2+-independent PKC isoforms during the first 2-3 hr of culture is essential for inducing apoptosis, and that Ca2+-dependent PKC isoforms may be influential, but not essential, for apoptosis. To assess the CD3/CD28-mediated activation of PKC in the apoptotic process, we prepared CD4+CD8+ thymocytes (without contamination with cells that had received negative or positive selection signals in vivo) by establishing TCR-transgenic mice with RAG-2-deficient and non-selecting major histocompatibility complex (MHC) backgrounds, in addition to a CD4+CD8+ thymocyte-enriched population from normal mice. Translocation of Ca2+-independent PKC from the cytosolic fraction to the particulate fraction of CD4+CD8+ thymocytes was induced by CD3/CD28-mediated stimulation, but not by CD3- or CD28-mediated stimulation alone, and peaked 2 hr after the start of culture. The kinase activity of the translocated Ca2+-independent PKC was dependent on cofactors in vitro, indicating that novel (n)PKC, but not atypical (a)PKC or a proteolytic PKC fragment, was responsible for the activity. Immunoblotting analysis indicated that the nPKC-theta isoform was the major contributor among nPKC isoforms, and that the classical (c)PKC-alpha isoform was the major contributor among cPKC isoforms. These results suggest that activation of nPKC (especially the theta isoform) in CD4+CD8+ thymocytes is involved in a pathway for negative selection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11106933      PMCID: PMC2327094          DOI: 10.1046/j.1365-2567.2000.00110.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  37 in total

1.  Inhibition of protein kinase C mu by various inhibitors. Differentiation from protein kinase c isoenzymes.

Authors:  M Gschwendt; S Dieterich; J Rennecke; W Kittstein; H J Mueller; F J Johannes
Journal:  FEBS Lett       Date:  1996-08-26       Impact factor: 4.124

2.  Differential induction of helper and killer T cells from isolated CD4+CD8+ thymocytes in suspension culture.

Authors:  M Iwata; T Kuwata; M Mukai; Y Tozawa; M Yokoyama
Journal:  Eur J Immunol       Date:  1996-09       Impact factor: 5.532

3.  Regulation of thymocyte lineage commitment by the level of classical protein kinase C activity.

Authors:  Y Ohoka; T Kuwata; A Asada; Y Zhao; M Mukai; M Iwata
Journal:  J Immunol       Date:  1997-06-15       Impact factor: 5.422

4.  CD28-B7 interactions function to co-stimulate clonal deletion of double-positive thymocytes.

Authors:  D Amsen; A M Kruisbeek
Journal:  Int Immunol       Date:  1996-12       Impact factor: 4.823

5.  Fas modulation of apoptosis during negative selection of thymocytes.

Authors:  J E Castro; J A Listman; B A Jacobson; Y Wang; P A Lopez; S Ju; P W Finn; D L Perkins
Journal:  Immunity       Date:  1996-12       Impact factor: 31.745

Review 6.  Regulation of protein kinase C.

Authors:  A C Newton
Journal:  Curr Opin Cell Biol       Date:  1997-04       Impact factor: 8.382

7.  Cross-linking of the TCR-CD3 complex with CD4, CD8 or LFA-1 induces an anti-apoptotic signal in thymocytes: the signal is canceled by FK506.

Authors:  Y Zhao; M Iwata
Journal:  Int Immunol       Date:  1995-09       Impact factor: 4.823

Review 8.  Regulation of T cell apoptosis via T cell receptors and steroid receptors.

Authors:  M Iwata; Y Ohoka; T Kuwata; A Asada
Journal:  Stem Cells       Date:  1996-11       Impact factor: 6.277

9.  Intrathymic signals in thymocytes are mediated by p38 mitogen-activated protein kinase.

Authors:  J Sen; R Kapeller; R Fragoso; R Sen; L I Zon; S J Burakoff
Journal:  J Immunol       Date:  1996-06-15       Impact factor: 5.422

10.  T cell receptor (TCR)-induced death of immature CD4+CD8+ thymocytes by two distinct mechanisms differing in their requirement for CD28 costimulation: implications for negative selection in the thymus.

Authors:  J A Punt; W Havran; R Abe; A Sarin; A Singer
Journal:  J Exp Med       Date:  1997-12-01       Impact factor: 14.307

View more
  4 in total

1.  SAP-mediated inhibition of diacylglycerol kinase α regulates TCR-induced diacylglycerol signaling.

Authors:  Gianluca Baldanzi; Andrea Pighini; Valentina Bettio; Elena Rainero; Sara Traini; Federica Chianale; Paolo E Porporato; Nicoletta Filigheddu; Riccardo Mesturini; Shuping Song; Tamas Schweighoffer; Laura Patrussi; Cosima T Baldari; Xiao-Ping Zhong; Wim J van Blitterswijk; Fabiola Sinigaglia; Kim E Nichols; Ignacio Rubio; Ornella Parolini; Andrea Graziani
Journal:  J Immunol       Date:  2011-11-02       Impact factor: 5.422

2.  Protein kinase C regulates mitochondrial targeting of Nur77 and its family member Nor-1 in thymocytes undergoing apoptosis.

Authors:  Jennifer Thompson; Megan L Burger; Hannah Whang; Astar Winoto
Journal:  Eur J Immunol       Date:  2010-07       Impact factor: 5.532

3.  Requirement of protein kinase D1 for pathological cardiac remodeling.

Authors:  Jens Fielitz; Mi-Sung Kim; John M Shelton; Xiaoxia Qi; Joseph A Hill; James A Richardson; Rhonda Bassel-Duby; Eric N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-14       Impact factor: 11.205

4.  Identification of novel Notch target genes in T cell leukaemia.

Authors:  Nicholas Chadwick; Leo Zeef; Virginia Portillo; Carl Fennessy; Fiona Warrander; Sarah Hoyle; Anne-Marie Buckle
Journal:  Mol Cancer       Date:  2009-06-09       Impact factor: 27.401

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.